Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Stage Study
July 17, 2024
Tickers
NEWS
RHHBY
Tags
RHHBY
General
Briefs
From
Benzinga
3 Small-Cap Stocks With Explosive 2X Growth Potential
July 08, 2024
Tickers
AMGN
BAYRY
CHPT
EXAI
Tags
RHHBY
VRDN
CHPT
From
InvestorPlace
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients
July 05, 2024
Tickers
MRK
NEWS
RHHBY
Tags
Briefs
News
RHHBY
From
Benzinga
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
June 27, 2024
Tickers
ABBV
BNTX
GMAB
JNJ
Tags
General
RHHBY
News
From
Benzinga
Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case
June 24, 2024
Tickers
AZN
GEHC
JNJ
NEWS
Tags
Media
Market News
Benzinga
From
Benzinga
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Tickers
AMGN
AZN
BMY
GILD
Tags
Jeffries
Briefs
General
From
Benzinga
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
June 21, 2024
Tickers
RHHBY
SRPT
Tags
RHHBY
SRPT
Today's Market
From
InvestorPlace
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
June 21, 2024
Tickers
NEWS
PFE
RGNX
RHHBY
Tags
General
RHHBY
Movers
From
Benzinga
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
June 07, 2024
Tickers
ABBV
FDMT
NEWS
REGN
Tags
REGN
ABBV
Trading Ideas
From
Benzinga
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations
June 06, 2024
Tickers
NEWS
NVS
RHHBY
Tags
Top Stories
NVS
Briefs
From
Benzinga
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
May 29, 2024
Tickers
ARKG
ARKK
DNA
RHHBY
Tags
ARKG
Market News
DNA
From
Motley Fool
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
May 26, 2024
Tickers
GS
RHHBY
VKTX
Tags
GS
Market News
Recent Press Releases
From
Motley Fool
Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
May 23, 2024
Tickers
AZN
GEHC
JNJ
PFE
Tags
JNJ
Stories That Matter
Briefs
From
Benzinga
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
Tickers
BHVN
GPCR
LLY
NEWS
Tags
RHHBY
News
Kaustubh Bagalkote
From
Benzinga
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate
May 16, 2024
Tickers
NEWS
RHHBY
Tags
Market News
Stories That Matter
Top Stories
From
Benzinga
Can Ocugen Stock Keep Churning Higher?
April 29, 2024
Tickers
OCGN
RHHBY
VHT
Tags
OCGN
Recent Press Releases
RHHBY
From
Motley Fool
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
April 24, 2024
Tickers
GILD
HOOK
NEWS
RHHBY
Tags
Biotech
Health Care
HOOK
From
Benzinga
2 Small-Cap Growth Stocks With Room To Run
April 24, 2024
Tickers
ACHR
OCUL
REGN
RHHBY
Tags
OCUL
Market News
ACHR
From
Motley Fool
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients
April 15, 2024
Tickers
HOOK
NEWS
RHHBY
RPTX
Tags
RHHBY
General
News
From
Benzinga
Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly 4.9%.
April 14, 2024
Tickers
HSBC
NVS
RHHBY
SHEL
Tags
SHEL
Market News
RHHBY
From
Motley Fool
Why Roche Holdings Stock Popped Today
April 11, 2024
Tickers
LLY
RHHBY
Tags
Market News
LLY
RHHBY
From
Motley Fool
Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.
April 10, 2024
Tickers
RHHBY
RXRX
Tags
RXRX
Market News
BAYR/Y
From
Motley Fool
Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data
April 08, 2024
Tickers
ALNY
NEWS
RHHBY
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs
March 22, 2024
Tickers
LLY
REGN
RHHBY
Tags
NYSE:LLY,NASDAQ:REGN,OTCMKTS:RHHBY
RHHBY
REGN
From
InvestorPlace
Why Is European Pharma Giant Argenx Valued At Over $20B Trading Higher On Thursday?
March 21, 2024
Tickers
ARGX
JNJ
NEWS
RHHBY
Tags
Market News
ARGX
Benzinga
From
Benzinga
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
March 20, 2024
Tickers
LZAGF
LZAGY
NEWS
RHHBY
Tags
Benzinga
Market News
Health Care
From
Benzinga
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
March 15, 2024
Tickers
BGNE
NEWS
NVS
RHHBY
Tags
Benzinga
FDA
Market News
From
Benzinga
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
March 11, 2024
Tickers
ASIA
ASML
AZN
GSK
Tags
Broad U/S/ Equity ETFs
Mid Cap
AZN
From
Benzinga
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
Tickers
ABBV
BGNE
GILD
NEWS
Tags
Stories That Matter
BGNE
Briefs
From
Benzinga
Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension Challenges
March 05, 2024
Tickers
ALNY
NEWS
RHHBY
Tags
Biotech
Large Cap
Equities
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.